What Is Ambien Medicine? Uses, Risks and Side Effects

Ambien is a brand name for zolpidem, a prescription sleep medication used to treat insomnia. It works by targeting specific receptors in the brain that promote sedation, helping people fall asleep faster and, in some formulations, stay asleep longer. Although it was originally marketed as a safer alternative to older sleeping pills, decades of real-world use have revealed a more complicated picture of both its benefits and its risks.

How Ambien Works in the Brain

Zolpidem belongs to a class of drugs sometimes called “Z-drugs,” which are distinct from older benzodiazepine sleeping pills like diazepam (Valium) or temazepam (Restoril), even though both drug classes act on the same general target in the brain. That target is a receptor called GABA-A, which is the main brake pedal for brain activity. When GABA-A receptors are activated, neurons fire less, and you feel drowsy.

What sets zolpidem apart from benzodiazepines is selectivity. It has a strong preference for one particular subtype of the GABA-A receptor, known as the alpha-1 subtype, while showing much weaker effects at other subtypes involved in muscle relaxation and anxiety reduction.¹ In practice, this means zolpidem is tuned fairly narrowly toward sedation. Research on brain cells shows that zolpidem specifically damps down the bursts of high-frequency activity in cortical neurons that keep you alert, rather than broadly suppressing all brain function the way a benzodiazepine might.² That selectivity is the reason zolpidem causes less muscle relaxation and less disruption to normal sleep architecture compared with benzodiazepines.³

What Ambien Is Prescribed For

Ambien’s approved use is for the short-term treatment of insomnia in adults. In its immediate-release form, the drug is mainly aimed at people who have trouble falling asleep at the start of the night. It kicks in quickly, usually within about 15 to 30 minutes, and clears the body relatively fast. An extended-release version was later approved to address both difficulty falling asleep and difficulty staying asleep, using a two-layer tablet design: one layer dissolves immediately, and a second layer releases the drug more slowly over the following hours.⁴ The extended-release version maintains effective drug levels during the middle portion of the sleep period, roughly three to six hours after you take it.⁵

Despite official guidance to use Ambien short-term, real-world prescribing tells a different story. In a survey examining how people actually use zolpidem, about 69% reported using it for long-term insomnia, and roughly 77% used it continuously rather than intermittently.⁶ This gap between intended use and actual use shapes many of the risks discussed below.

Available Formulations

You might see zolpidem prescribed under different brand names or in different delivery formats, and the differences matter for how and when you take it:

Immediate-release tablets: The original Ambien. Taken at bedtime when you have a full night (seven to eight hours) ahead of you.
Extended-release tablets: Ambien CR. Also taken at bedtime but designed to help with both falling asleep and staying asleep through its bilayer design.
Sublingual low-dose tablet: A formulation approved specifically for middle-of-the-night wakefulness. It dissolves under the tongue at a lower dose and is meant for those moments when you wake at 2 a.m. and cannot get back to sleep, provided you still have at least four hours of sleep time remaining.⁷

The sublingual version was tested in people with insomnia who averaged over an hour of wakefulness after waking up mid-sleep. Over four weeks, it cut that time from about 68 minutes down to about 38 minutes, a meaningful improvement over placebo.⁸

Why Doses Differ for Women and Men

In 2013, the FDA took the unusual step of recommending lower starting doses of zolpidem for women. The reason comes down to how quickly the body clears the drug. Research has found that women have, on average, about 35% lower clearance of zolpidem compared with men, meaning the drug lingers in their bloodstream longer.⁹ This difference was not explained by body weight alone. The practical result is that a woman taking the same dose as a man is more likely to have enough drug in her system the next morning to impair driving or alertness. The recommended starting dose for women is 5 mg for immediate-release and 6.25 mg for extended-release, compared with 5 to 10 mg and 6.25 to 12.5 mg for men.

Common Side Effects

The most frequently reported side effects of Ambien are drowsiness that carries into the next day, dizziness, headache, and a feeling of being drugged or groggy in the morning. Most of these relate to the same sedation the drug is designed to produce. They tend to be more pronounced at higher doses and in people who do not get a full night’s sleep after taking it.

Next-morning impairment deserves special attention because it has real safety consequences. Studies using standardized highway driving tests found that after a bedtime dose of zolpidem, driving performance the next morning was significantly impaired compared to placebo.¹⁰ Even the low-dose sublingual formulation, designed for middle-of-the-night use, showed measurable driving impairment three hours after dosing, though the effect largely resolved by four hours.¹¹ The bottom line: do not drive or operate machinery until you are fully alert, and be honest with yourself about how the drug is affecting you the following day.

Complex Sleep Behaviors

The side effect that has drawn the most public alarm is what researchers call complex sleep behaviors. These are activities people perform while still essentially asleep after taking zolpidem, with little or no memory of them the next day. The range of reported behaviors is startlingly wide: sleepwalking, eating while asleep, cooking, shopping online, engaging in sexual activity, and driving a car.¹²

One well-documented case involved a woman who began walking, eating, and on one occasion driving while asleep after starting zolpidem. Brain imaging performed during these episodes showed unusual patterns of activity, with some brain regions “awake” while others remained in a sleep-like state.¹³ These behaviors are not just curiosities. Sleep-driving can result in accidents, and sleep-eating episodes often involve consuming unusual or dangerous items. The FDA added a black-box warning to all zolpidem products, the most prominent type of safety alert, requiring that patients who experience any such episode discontinue the drug permanently.

The risk factors for complex sleep behaviors are not fully nailed down, but higher doses, combining zolpidem with alcohol or other sedating drugs, and taking the drug without immediately going to bed all appear to increase the likelihood.

Risks for Older Adults

Ambien carries elevated risks for people over 65. Older adults metabolize the drug more slowly, leaving higher levels in the body for longer. One of the most concerning consequences is fractures from falls. A study of elderly insomnia patients found that zolpidem use was associated with roughly 72% greater odds of fracture.¹⁴ A separate study put the figure even higher, finding nearly double the risk of hip fracture specifically in older zolpidem users, even after accounting for other health factors.¹⁵

What makes these findings stand out is the comparison with benzodiazepines. Zolpidem was originally promoted as a safer choice for older patients precisely because it was supposed to cause less muscle relaxation and less daytime drowsiness. Yet these fracture data suggest the fall risk is at least as high as, and possibly higher than, that seen with older-generation sleeping pills. The cognitive and psychomotor impairment caused by any sedative-hypnotic, including zolpidem, can compromise balance and reaction time in people whose physical reserves are already limited.¹⁶ For older adults, non-drug approaches to insomnia are generally the preferred first step.

Dependence, Abuse, and What Happens When You Stop

When zolpidem first entered the market, it was widely described as having minimal addiction potential. That narrative has eroded. Data from pharmacovigilance networks and published case reports provide substantial evidence that zolpidem carries real potential for both abuse and dependence.¹⁷ Some users escalate their dose over time, and others report feeling unable to sleep at all without it after extended use. This pattern is reinforced by the high proportion of patients who end up taking the drug continuously for months or years, well beyond the recommended duration.

What happens when you stop is complicated. A 12-month clinical trial of nightly zolpidem use at standard doses found that, as a group, patients did not develop clinically meaningful rebound insomnia or withdrawal symptoms. About 30 to 40% of individual participants did show rebound sleep difficulty on discontinuation nights, but that proportion did not differ from the placebo group, suggesting some of it was the return of the underlying insomnia rather than a drug-withdrawal effect.¹⁸

However, clinical trial data at therapeutic doses do not capture the full picture. Case reports and post-marketing surveillance have documented withdrawal symptoms after stopping zolpidem abruptly, including fatigue, nausea, stomach cramps, panic attacks, nervousness, muscle cramps, flushing, and restlessness.¹⁹ These reports tend to involve people who were using higher-than-prescribed doses or who had been taking the drug for extended periods. Gradual tapering, rather than abrupt discontinuation, is the standard recommendation for anyone who has been on zolpidem for more than a few weeks.

Genetic Differences in How Your Body Handles Zolpidem

Zolpidem is broken down primarily by liver enzymes, and genetic variation in those enzymes can make a significant difference in how quickly you metabolize the drug. Research in the Chinese Han population found that specific genetic variants in two key enzymes, CYP3A4 and CYP2C19, were correlated with the speed of zolpidem metabolism. People with certain CYP2C19 variants cleared the drug much more slowly, meaning higher blood levels for longer.²⁰

For people who metabolize zolpidem slowly, the practical consequences can be serious. A case series from a psychiatry practice flagged nine patients who experienced severe adverse reactions to zolpidem. These individuals appeared to be poor metabolizers and were also taking SSRI or SNRI antidepressants, which can further slow the breakdown of zolpidem through drug-drug interactions.²¹ If you feel unusually groggy, disoriented, or impaired after taking zolpidem, genetic metabolism differences are a plausible explanation, and your prescriber should know about it.

Alcohol and Other Drug Interactions

Mixing Ambien with alcohol is one of the most dangerous things you can do with the drug, and it is also one of the most common. Both substances are central nervous system depressants, and their combined effect is more than additive. Drinking alcohol while taking zolpidem increases the risk of excessive sedation, respiratory depression, and loss of consciousness. The complex sleep behaviors discussed earlier also become more likely with alcohol in the mix. The same warning extends to opioids, benzodiazepines, and other sedating medications. Taking zolpidem alongside any of these raises the stakes considerably.

The drug’s presence in impaired-driving cases underscores the interaction risk. Zolpidem has been identified in the blood of drivers arrested for impaired driving, sometimes in combination with alcohol or other drugs.²² As the most widely prescribed sleep aid in the United States, it appears with increasing frequency in forensic specimens involved in motor vehicle incidents and other medicolegal investigations.²³

How Ambien Compares to Other Approaches

One of the most important things to know about Ambien is how it stacks up against non-drug treatment. Cognitive behavioral therapy for insomnia (CBT-I), a structured program that addresses the thoughts and habits perpetuating poor sleep, has been compared head-to-head with zolpidem. In a randomized trial, CBT-I reduced the time it took to fall asleep by about 52%, while zolpidem alone produced only a 14% reduction, barely different from placebo. The combination of CBT-I and medication performed similarly to CBT-I alone.²⁴ That is a striking result and the reason most sleep medicine guidelines now recommend CBT-I as the first-line treatment, with medication reserved for when behavioral approaches are insufficient or unavailable.

Within the medication world, newer drugs called orexin receptor antagonists (such as suvorexant) work through a completely different mechanism. Rather than broadly sedating the brain, they block the wakefulness signal produced by orexin. Sleep studies comparing the two found that suvorexant produces brainwave patterns during sleep that more closely resemble natural sleep than those seen with zolpidem.²⁵ Zolpidem was better at reducing the time it took to fall asleep, while suvorexant was better at reducing nighttime awakenings. Neither drug is perfect, and the best choice depends on whether your main struggle is falling asleep or staying asleep.

An Unexpected Use in Brain Injury

One of the more surprising findings in zolpidem research has nothing to do with insomnia. Some patients with severe brain injuries, including people in states of minimal consciousness, have shown short-term neurological improvements after taking the drug. These improvements can include temporary recovery of awareness, motor function, or speech.²⁶ The effect is paradoxical: a drug meant to make people sleepy appears, in certain damaged brains, to reactivate circuits that have gone silent. The phenomenon remains rare and poorly understood, and it is not something that works for most brain-injury patients. But it has generated genuine scientific interest as a window into how damaged neural networks can sometimes be “restarted,” and clinical research in this area is ongoing.

When Taking Ambien Makes Sense and When It Does Not

Ambien fills a specific niche. It works fast, it targets sedation without as many side effects as older sleeping pills, and for short-term insomnia, especially the kind triggered by jet lag, a stressful life event, or a temporary disruption to your routine, it can be genuinely helpful. Where the picture gets murkier is with long-term, nightly use. The drug was not designed for that pattern, the evidence base for chronic use is thinner, and the risks of dependence, falls, next-day impairment, and complex sleep behaviors accumulate over time.

If you are considering Ambien or already taking it, a few practical points are worth keeping in mind. Always take it immediately before getting into bed with a full night of sleep ahead. Never combine it with alcohol. If you are a woman or over 65, a lower dose is likely appropriate. Report any next-day grogginess or any episodes of doing things you do not remember to your prescriber right away. And if you have been taking it for more than a few weeks and want to stop, talk to your doctor about a tapering schedule rather than quitting abruptly. For many people with chronic insomnia, the best long-term investment is not a pill but a structured behavioral program that retrains the brain’s relationship with sleep.